Modulating ROS to overcome multidrug resistance in cancer
The successful treatment of cancer has significantly improved as a result of targeted therapy
and immunotherapy. However, during chemotherapy, cancer cells evolve and can acquire …
and immunotherapy. However, during chemotherapy, cancer cells evolve and can acquire …
[PDF][PDF] Pharmaceutical approaches to colon targeted drug delivery systems
MK Chourasia, SK Jain - J Pharm Pharm Sci, 2003 - ualberta.ca
Purpose. Although oral delivery has become a widely accepted route of administration of
therapeutic drugs, the gastrointestinal tract presents several formidable barriers to drug …
therapeutic drugs, the gastrointestinal tract presents several formidable barriers to drug …
Guidelines of care for the management of psoriasis and psoriatic arthritis: section 4. Guidelines of care for the management and treatment of psoriasis with traditional …
A Menter, NJ Korman, CA Elmets, SR Feldman… - Journal of the American …, 2009 - Elsevier
Psoriasis is a common, chronic, inflammatory, multisystem disease with predominantly skin
and joint manifestations affecting approximately 2% of the population. In this fourth of 6 …
and joint manifestations affecting approximately 2% of the population. In this fourth of 6 …
[HTML][HTML] History of inflammatory bowel diseases
GC Actis, R Pellicano, S Fagoonee… - Journal of clinical …, 2019 - mdpi.com
Inflammatory bowel diseases (IBD) are characterized by chronic inflammation of the
intestinal mucosa and unknown etiology. In this review, we identified three main eras in the …
intestinal mucosa and unknown etiology. In this review, we identified three main eras in the …
Characterization of drugs as antioxidant prophylactics
OI Aruoma - Free Radical Biology and Medicine, 1996 - Elsevier
There is growing interest in the evaluation of drugs (prescription only medicines and over-
the-counter medicines) as antioxidant prophylactics. Although free radical mechanism in …
the-counter medicines) as antioxidant prophylactics. Although free radical mechanism in …
Pharmacology and potential therapeutic applications of nitric oxide‐releasing non‐steroidal anti‐inflammatory and related nitric oxide‐donating drugs
This review examines the biological significance, therapeutic potential and mechanism (s) of
action of a range of nitric oxide‐releasing non‐steroidal anti‐inflammatory drugs (NO …
action of a range of nitric oxide‐releasing non‐steroidal anti‐inflammatory drugs (NO …
Drug insight: aminosalicylates for the treatment of IBD
OH Nielsen, LK Munck - Nature clinical practice Gastroenterology & …, 2007 - nature.com
Sulfasalazine and mesalazine (also known as mesalamine; 5-aminosalicylic acid)
preparations have for many years been used for the treatment of IBD (ie ulcerative colitis …
preparations have for many years been used for the treatment of IBD (ie ulcerative colitis …
[PDF][PDF] Guidelines of care for the management of psoriasis and psoriatic arthritis
A Menter, NJ Korman, CA Elmets, SR Feldman… - Journal of the American …, 2009 - piel-l.org
Guidelines of care for the management of psoriasis and psoriatic arthritis Page 1 FROM THE
ACADEMY Guidelines of care for the management of psoriasis and psoriatic arthritis Section 4 …
ACADEMY Guidelines of care for the management of psoriasis and psoriatic arthritis Section 4 …
[HTML][HTML] Neurological disorders and inflammatory bowel diseases
G Casella, GE Tontini, G Bassotti… - World Journal of …, 2014 - ncbi.nlm.nih.gov
Extraintestinal manifestations occur in about one-third of patients living with inflammatory
bowel disease (IBD) and may precede the onset of gastrointestinal symptoms by many …
bowel disease (IBD) and may precede the onset of gastrointestinal symptoms by many …
Novel oral colon-specific drug delivery systems for pharmacotherapy of peptide and nonpeptide drugs.
SM Reddy, VR Sinha, DS Reddy - Drugs of Today (Barcelona …, 1999 - europepmc.org
The increasing number of peptide and protein drugs being investigated demands the
development of dosage forms which exhibit site-specific release. Delivery of drugs into …
development of dosage forms which exhibit site-specific release. Delivery of drugs into …